IGF1 and breast carcinoma: IGF-I and EGF are potent mitogens for breast cancer cells inducing cellular proliferation and promoting the invasiveness and endocrine- or chemotherapeutic resistance of T-47D and MCF7 breast cancer cells [51-55].